Physician

Abir Khan

According to 2025 Medicare claims, Abir Khan (NPI: 1811424146) practices hematology/oncology in the Rocky Mount, NC market, with the plurality of this provider's patient population coming from Nash, NC. This provider's primary affiliated billing organization is NHCS PHYSICIANS, INC. (NPI: 1932652492; TIN: 471182549) and primary practice location at 27804-2237.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 162 traditional Medicare patients, billed 466 HCPCS/CPT codes, and received $25,363 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 993 prescription claims across 157 beneficiaries totaling $1,803,017 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 11 claims. Open Payments data shows 10 records totaling $177. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,447 to $1,803,017. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$13K$25K2023 Medicare payment: $3,183 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $25,363 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20232940$3,183
2024162466$25,363

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$902K$1.8M2018 Drug cost: $5,447 (USD; Tot_Drug_Cst)2019 Drug cost: $151 (USD; Tot_Drug_Cst)2021 Drug cost: $136,229 (USD; Tot_Drug_Cst)2022 Drug cost: $507,765 (USD; Tot_Drug_Cst)2023 Drug cost: $55,737 (USD; Tot_Drug_Cst)2024 Drug cost: $1,803,017 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R26$5,447
2019N/R14$151
2020N/RN/RN/R
202133174$136,229
202236188$507,765
20232971$55,737
2024157993$1,803,017

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$226$4522024 Medicare payment: $452 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R11$452

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more2525$81
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more49103$62
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more5252$51
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more98231$47
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more2326$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LenalidomideLenalidomide451,260$650,637
RevlimidLenalidomide21588$366,448
Abiraterone AcetateAbiraterone Acetate22660$70,500
EliquisApixaban401,346$25,609
AnastrozoleAnastrozole1688,453$2,238

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R11$452

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$177Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abir Khan?

Tedicare shows public-source Medicare data for Abir Khan (NPI 1811424146), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abir Khan have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abir Khan?

Abir Khan is linked to NHCS PHYSICIANS, INC. (billing NPI 1932652492) in the available physician profile data.

Does Abir Khan have Open Payments data?

Abir Khan has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.